Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Re Yan Ning mixture for upper respiratory tract infection (wind heat invasion, lung and stomach heat excess syndrome)
ChiCTR2500109030Phase 4Not yet recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Reyanning mixture in upper respiratory infection (URI) (3 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoint: Disease recovery time. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
Reyanning mixture
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on ChiCTR2500109030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109030.